Analysis of plasma samples revealed significantly higher VTN expression in CRC patient plasma (331.56 ± 32.25 μg/mL) compared to the healthy control group (237.79 ± 23.08 μg/mL) (P = 0.0215) (Figure 1P). The gene discussed is VTN; the disease is colorectal carcinoma.